about the author

Max Gelman writes about the big-picture ideas and trends that drive the biopharma world, with particular interests in immunology and neuroscience. A graduate of Northwestern University, Max joined Endpoints in July 2020 after a few stints covering baseball and college sports. He currently lives in New York City.

author articles